First Financial Bank - Trust Division - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
First Financial Bank - Trust Division ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$74,000
+42.3%
13,3200.0%0.01%
+37.5%
Q2 2018$52,000
-17.5%
13,3200.0%0.01%
-20.0%
Q1 2018$63,000
+14.5%
13,3200.0%0.01%
+11.1%
Q4 2017$55,000
-34.5%
13,3200.0%0.01%
-35.7%
Q3 2017$84,000
-19.2%
13,3200.0%0.01%
-22.2%
Q2 2017$104,000
+18.2%
13,3200.0%0.02%
+12.5%
Q1 2017$88,000
-4.3%
13,3200.0%0.02%
-11.1%
Q4 2016$92,000
-25.8%
13,3200.0%0.02%
-21.7%
Q3 2016$124,000
+0.8%
13,3200.0%0.02%
-4.2%
Q2 2016$123,000
+6.0%
13,3200.0%0.02%
+4.3%
Q1 2016$116,000
+28.9%
13,3200.0%0.02%
+27.8%
Q4 2015$90,000
+16.9%
13,3200.0%0.02%
+5.9%
Q3 2015$77,000
-29.4%
13,3200.0%0.02%
-26.1%
Q2 2015$109,0000.0%13,3200.0%0.02%
+4.5%
Q1 2015$109,000
-10.7%
13,3200.0%0.02%
-4.3%
Q4 2014$122,000
-6.9%
13,3200.0%0.02%
-11.5%
Q3 2014$131,00013,3200.03%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Round Table Services, LLC 129,500$1,207,0000.72%
STONERIDGE INVESTMENT PARTNERS LLC 252,376$2,352,0000.34%
Bellevue Group AG 155,000$1,445,0000.26%
WASATCH ADVISORS LP 1,861,553$17,350,0000.26%
Blue Clay Capital Management, LLC 13,000$121,0000.14%
Virtus ETF Advisers LLC 24,058$224,0000.11%
EMERALD ADVISERS, LLC 203,737$1,899,0000.08%
Vident Investment Advisory, LLC 63,383$591,0000.08%
Thomas J. Herzfeld Advisors, Inc. 15,000$140,0000.08%
GSA CAPITAL PARTNERS LLP 94,400$880,0000.05%
View complete list of INOVIO PHARMACEUTICALS INC shareholders